Regeneron Pharmaceuticals, Inc.
HUMAN SERUM ALBUMIN IN FORMULATIONS
Last updated:
Abstract:
Drug formulations and methods for removing, reducing, or preventing the formation of fatty acid particles in drug formulations are provided.
Status:
Application
Type:
Utility
Filling date:
30 Dec 2021
Issue date:
21 Apr 2022